Destruxins: Fungal-derived Cyclohexadepsipeptides with Multifaceted Anticancer and Antiangiogenic Activities

Por Dornetshuber-Fleiss, R., Heffeter, P., Mohr, T., Hazemi, P., Kryeziu, K., Seger, C., Berger, W., Lemmens-Gruber, R.
Publicado no Biochem Pharmacol (2013)

Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)

Por Heffeter, P., Jakupec, M.A., Körner, W., Chiba, P., Pirker, C., Dornetshuber, R., Elbling, L., Sutterlüty, H., Micksche, M., Keppler, B.K., Berger, W.
Publicado em 2007

Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance

Por Englinger, B, Mair, M, Miklos, W, Pirker, C, Mohr, T, van Schoonhoven, S, Lötsch, D, Körner, W, Ferk, F, Knasmüller, S, Heffeter, P, Keppler, B K, Grusch, M, Berger, W
Publicado no Br J Cancer (2017)

Multi-scale imaging of anticancer platinum(iv) compounds in murine tumor and kidney

Por Legin, A. A., Theiner, S., Schintlmeister, A., Reipert, S., Heffeter, P., Jakupec, M. A., Mayr, J., Varbanov, H. P., Kowol, C. R., Galanski, M. S., Berger, W., Wagner, M., Keppler, B. K.
Publicado no Chem Sci (2016)

Ribonucleotide Reductase as One Important Target of [Tris(1,10-phenanthroline)lanthanum(III)] Trithiocyanate (KP772)

Por Heffeter, P., Popovic-Bijelic, A., Saiko, P., Dornetshuber, R., Jungwirth, U., Voevodskaya, N., Biglino, D., Jakupec, M.A., Elbling, L., Micksche, M., Szekeres, T., Keppler, B.K., Gräslund, A., Berger, W.
Publicado em 2009

Long-term exposure of immortalized keratinocytes to arsenic induces EMT, impairs differentiation in organotypic skin models and mimics aspects of human skin derangements

Por Weinmuellner, R., Kryeziu, K., Zbiral, B., Tav, K., Schoenhacker-Alte, B., Groza, D., Wimmer, L., Schosserer, M., Nagelreiter, F., Rösinger, S., Mildner, M., Tschachler, E., Grusch, M., Grillari, J., Heffeter, P.
Publicado no Arch Toxicol (2017)